In their research activities or in their quality control obligations, pharmaceutical companies are major producers and consumers of morphological images both in brightfield and in fluorescence. Digital pathology allows these companies to perform high-throughput screening on molecules and to work on a series of slides with efficiency and consistency. Uses can be in Drug Discovery or in toxicopathology.

TRIBVN delivers its expertise by providing them with high-speed scanning solutions with an integrated environment built around the CaloPix software. Moreover its ability to design and deploy screening automation equipements enables TRIBVN to answer to specific requests from Biotech which have innovative diagnostic solutions.